Ocular manifestations and treatment of Lyme disease

Current Opinion in Ophthalmology

Volumn 7, Issue 3, 1996, Pages 7-12

  Karma, Anni ^a   Mikkilä, Helena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE;

ANTIBIOTIC THERAPY; BILIARY TRACT DISEASE; BIOMICROSCOPY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HERXHEIMER REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; OCULOGRAPHY; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS;

EID: 0029743766     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199606000-00002     Document Type: Review

References (46)

1. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP: Lyme disease: a tick-borne spirochetosis? Science 1982, 216:1317-1319.
2. Lebech A-M, Hansen K, Wilske B, Theisen M: Taxonomic classification of 29 Borrelia burgdorferi strains isolated from patients with Lyme borreliosis: a comparison of five different phenotypic and genotypic typing schemes. Med Microbiol Immunol 1994, 183:325-341.
3. Demaerschalck I, Messaoud AB, De Kesel M, Hoyois B, Lobet Y, Hoet P, Bigaignon G, Bollen A, Godfroid E: Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol 1995, 33:602-608. Biologic fluids from patients with neuroborreliosis were examined by PCR. Genospecies-specific primers to type all B. burgdorferi sensu lato strains were used. The results underscored the relatively high prevalence of pluri-infections in Lyme disease and confirmed the association of B. garinii with neuroborreliosis.
4. Steere AC: Medical progress: Lyme disease. N Engl J Med 1989, 321:586-596.
5. Steere AC, Duray PH, Kauffmann DJH, Wormser GP: Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985, 103:382-384.
6. Winward KE, Smith JL, Culbertson WW, Paris-Hamelin A: Ocular Lyme borreliosis. Am J Ophthalmol 1989, 108:651-657.
7. Lesser RL, Kornmehl EW, Pachner AR, Kattah J, Hedges TR III, Newman NM, Ecker PA, Glassman MI: Neuro-ophthalmologic manifestations of Lyme disease. Ophthalmology 1990, 97:699-706.
8. Smith JL: Neuro-ocular Lyme borreliosis. Neurol Clin 1991, 9:35-53.
9. Karma A, Seppälä I, Mikkilä H, Kaakkola S, Viljanen M, Tarkkanen A: Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol 1995, 119:127-135. Ten patients with ocular Lyme borreliosis are described. Abnormalities of the posterior segment such as vitreitis, retinal vasculitis, neuroretinitis, choroiditis, and optic neuropathy were seen in six patients. Paralytic mydriasis, interstitial keratitis, episcleritis, and anterior uveitis were seen in one patient each. Ocular borrelial manifestations show characteristics resembling those seen in syphilis. The authors emphasized that late-phase ocular borreliosis may be difficult to diagnose because of seronegativity or weak seropositivity in ELISA assays.
10. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringner Å, Elmrud H, Carlsson M, Runehagen A, Svanborg C, Norrby R: An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995, 333:1319-1324. An epidemiologic survey of 1471 cases of Lyme disease was carried out. Lyme disease was found to be very common in southern Sweden, with a relatively high frequency of neurologic complications and arthritis. No ophthalmic changes were reported in this study.
11. Centers for Disease Control: Case definitions for public health surveillance: Lyme disease. MMWR Morb Mortal Wkly Rep 1990, 13:19-21.
12. Steere AC, Taylor E, McHugh GL, Logigian EL: The overdiagnosis of Lyme disease. JAMA 1993, 269:1812-1816.
13. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppälä I: Late Lyme borreliosis: epidemiology, diagnosis and clinical features. Ann Med 1993, 25:349-352.
14. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, Sigal LH, Spieler PN, Stenn KS, Malawista SE: The early clinical manifestations of Lyme disease. Ann Intern Med 1983, 99:76-82.
15. Lesser RL: Ocular manifestations of Lyme disease. Am J Med 1995, 8(suppl 4A):60-62. The spectrum of ocular manifestations in Lyme borreliosis is briefly reviewed.
16. Garcia-Monco JC, Villar FB, Alen JC, Benach JL: Borrelia burgdorferi in the central nervous system: experimental and clinical evidence for early invasion. J Infect Dis 1990, 161:1187-1193.
17. Junttila J, Tanskanen R, Tuomi J: Prevalence of Borrelia burgdorferi in selected tick populations in Finland. Scand J Infect Dis 1994, 26:349-355.
18. Tuomi J, Rantamäki LK, Tanskanen R, Junttila J: Characterization of Finnish Borrelia burgdorferi sensu lato isolates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and with monoclonal antibodies. J Clin Microbiol 1995, 33:1989-1996. Borrelia burgdorferi strains were isolated from ticks collected from different regions in Finland. The study demonstrates that all the species of B. burgdorferi sensu lato occur in the Finnish population of Ixodes ricinus ticks.
19. Szer IS, Taylor E, Steere AC: The long-term course of Lyme arthritis in children. N Engl J Med 1991, 325:159-163.
20. Preac-Mursic V, Pfister HW, Spiegel H, Burk R, Wilske B, Reinhardt S, Römer R: First isolation of Borrelia burgdorferi from an iris biopsy. J Clin Neuroophthalmol 1993, 13:155-161.
21. Schubert HD, Greenebaum E, Neu HC: Cytologically proven seronegative Lyme choroiditis and vitritis. Retina 1994, 14:39-42.
22. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG: Seronegative Lyme disease: dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med 1988, 319:1441-1446.
23. Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J: Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 1990, 335:312-315.
24. Oksi J, Uksila J, Marjamäki M, Nikoskelainen J, Viljanen MK: Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41-kilodalton flagellin, and P39 protein in patients with PCR- or culture-proven late Lyme borreliosis. J Clin Microbiol 1995, 33:2260-2264. The sensitivities and specificities of three ELISAs for B. burgdorferi antibodies were evaluated in patients with culture- or PCR-proven late Lyme borreliosis. The results show that antibodies to B. burgdorferi may be present in low levels or even absent in patients with late Lyme borreliosis. Therefore, in addition to serologic testing, the use of PCR and cultivation is recommended in the diagnosis of Lyme borreliosis.
25. Liegner KB: Lyme disease: the sensible pursuit of answers. J Clin Microbiol 1993, 31:1961-1963.
26. Karma A, Pirttilä TA, Viljanen MK, Lähde YE, Raitta CM: Secondary retinitis pigmentosa and cerebral demyelination in Lyme borreliosis. Br J Ophthalmol 1993, 77:120-122.
27. Linna T, Mikkilä H, Karma A, Seppälä I, Petroll WM, Tervo T: In vivo confocal microscopy: a new possibility to confirm the diagnosis of Borrelia keratitis? Cornea 1996, in press.
28. Kimura K, Isogai E, Isogai H, Nishikawa T, Masuzawa T, Yoshikawa K, Kotake S, Ohno S, Fujii N: Prevalence of antibodies against Borrelia species in patients with unclassified uveitis in regions in which Lyme disease is endemic. Clin Diagn Lab Immunol 1995, 2:53-56. Serum antibodies against B. burgdorferi were studied in patients with unclassified uveitis in regions where Lyme disease is endemic versus regions where it is nonendemic. The prevalence of antibodies was significantly higher in patients with unclassified uveitis in endemic areas than in uveitis patients in nonendemic areas and in control patients. The authors emphasized that Lyme borreliosis should be considered in patients with unclassified uveitis, especially in endemic areas.
29. Rosenbaum JT, Rahn DW: Prevalence of Lyme disease among patients with uveitis. Am J Ophthalmol 1991, 112:462-463.
30. Breeveld J, Kuiper H, Spanjaard L, Luyendijk L, Rothova A: Uveitis and Lyme borreliosis. Br J Ophthalmol 1993, 77:480-481.
31. Hoang-Xuan T, Menuet C, Abirached G: Kératite dans la maladie de Lyme [in French]. J Fr Ophtalmol 1994, 17:513-521.
32. Carpenetti SR, Sulewski ME, Ringel DM: Lyme disease related keratitis. Ann Ophthalmol 1995, 27:101-106. The authors described corneal changes in three patients with Lyme disease-related keratitis. They emphasized that Lyme borreliosis should be included in the differential diagnosis of unusual keratitis.
33. Culbertson WW, Winward KE, Smith JL: Atypical intermediate uveitis (pars planitis) associated with Lyme borreliosis. In Ocular Immunology Today. Edited by Usui M, Aoki K. Amsterdam: Elsevier Publishers, 1990:241-243.
34. Rothova A, Kuiper H, Spanjaard L, Dankert J, Breebaart AC: Spiderweb vitritis in Lyme borreliosis. Lancet 1991, 337:490-491.
35. Wilk CM, Bialasiewicz AA, Ruprecht KW, Naumann GOH: Bilaterale akute konfluierende Chorioiditis disseminata bei Borrelia burgdorferi-Infektion [in German]. Klin Monatsbl Augenheilkd 1989, 194:88-96.
36. Wiegand W: Augenbefunde bei Borreliose: bilaterale Panuveitis mit exudativer Amotio [in German]. Fortschr Ophthalmol 1989, 86:659-662.
37. Duke-Elder S, Perkins ES: Diseases of the uveal tract. In System of Ophthalmology, vol 9. Edited by Duke-Elder S. London: Kimpton: 1966: 296-321.
38. Bodine SR, Marino J, Camisa TJ, Salvate AJ: Multifocal choroiditis with evidence of Lyme disease. Ann Ophthalmol 1992, 24:169-173.
39. Swuttorp-Schulten MSA, Luyendijk L, van Dam AP, de Keizer RJW, Baarsma GS, Bos PJM, Rothova A: Birdshot chorioretinopathy and Lyme borreliosis. Am J Ophthalmol 1993, 115:149-153.
40. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppälä I: Treatment of late Lyme borreliosis. J Infect 1994, 29:255-261.
41. Suttorp-Schulten MSA, Kuiper H, Kijlstra A, van Dam AP, Rothova A: Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis. Am J Ophthalmol 1993, 116:571-575.
42. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ: Treatment of late Lyme neuroborreliosis: a randomized comparison of ceftriaxone and penicillin. Lancet 1988, i:1191-1194.
43. Strominger MB, Slamovits TL, Herskovitz S, Lipton RB: Transient worsening of optic neuropathy as a sequela of the Jarisch-Herxheimer reaction in the treatment of Lyme disease. J Neuroophthalmol 1994, 14:77-80.
44. Ettestad PJ, Campbell GL, Welbel SF, Genese CA, Spitalny KC, Marchetti CM, Dennis DT: Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis 1995, 171:356-361. The study shows that treatment of unsubstantiated Lyme disease with intravenous ceftriaxone is associated with biliary complications.
45. Preac-Mursic V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, Prokop J: Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 1989, 17:355-359.
46. Liegner KB, Shapiro JR, Ramsay D, Halperm AJ, Hogrefe W, Kong L: Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persistent Borrelia burgdorferi infection. J Am Acad Dermatol 1993, 28:312-314.